FDA
-
-
-
-
-
-
-
Foghorn Therapeutics (FHTX) Announces Chief Medical Officer Succession
-
-
-
-
-
-
-
Foghorn Therapeutics Provides an Update on FHD-609
-
-
-
-
-
-
-
Foghorn Therapeutics Provides Third Quarter 2022 Financial and Corporate Update
-
-
-
-
-
-
-
After-Hours Stock Movers 05/19: Palo Alto Ramps on Strong Results; Ross Stores Plunges (more...)
-
-
-
-
-
-
-
Foghorn Therapeutics Provides Second Quarter 2021 Corporate Update
-
-
-
-
-
-
-
Foghorn Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
-
325,893 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

